Chromosomal Abnormalities in Couples with Reproductive DisordersMeza-Espinoza J.P.a · Ortiz Anguiano L.b · Rivera H.c
aUnidad Academica de Ciencias de la Salud y Tecnologia, Universidad Autonoma de Tamaulipas, Matamoros; bCUCEI-U de G and cDoctorado en Genetica Humana, Universidad de Guadalajara and Instituto Mexicano del Seguro Social, Guadalajara, Mexico
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Aim: To determine the prevalence of chromosomal abnormalities in couples with reproductive disorders. Methods: A retrospective study was performed in 939 Mexican couples with reproductive disorders (542 with recurrent fetal loss, 356 with malformed/stillborn children, and 41 with sterility) whose karyotype was established on GTG-banded metaphases. Results: A chromosomal aberration was detected in one partner of 52 couples, including a double translocation carrier; therefore, the prevalence of chromosomally abnormal couples was 5.5%; 31 couples with recurrent fetal loss (31/542, 5.7%), 15 with malformed/stillborn children (15/356, 4.2%), and 6 with sterility (6/41, 14.6%). There were 43 couples with structural rearrangements (29 reciprocal translocations, 10 robertsonian translocations, 2 inversions, 1 insertion, and 1 ring) and 9 with gonosomal aneuploidies. The affected partner was female in 28 (53.8%) and male in 24 (46.2%) couples. In addition, 17 couples (1.8%) with the structural variant inversion 9qh were detected. Conclusion: The prevalence of chromosomal abnormalities found in our sample is consistent with figures described in several populations around the world.
© 2008 S. Karger AG, Basel
- Templeton A: Infertility and the establishment of pregnancy-overview. Br Med Bull 2000;56:577–587.
- Duzcan F, Atmaca M, Cetin GO, Bagci H: Cytogenetic studies in patients with reproductive failure. Acta Obstet Gynecol Scand 2003;82:53–56.
- Fryns JP, Kleczkowska A, Kubien E, Petit P, Van den Berghe H: Cytogenetic survey in couples with recurrent fetal wastage. Hum Genet 1984;65:336–354.
- Bourrouillou G, Colombies P, Dastugue N: Chromosome studies in 2,136 couples with spontaneous abortions. Hum Genet 1986;74:399–401.
- Portnoi MF, Joye N, van den Akker J, Morlier G, Taillemite JL: Karyotypes of 1,142 couples with recurrent abortion. Obstet Gynecol 1988;72:31–34.
- Makino T, Tabuchi T, Nakada K, Iwasaki K, Tamura S, Iizuka R: Chromosomal analysis in Japanese couples with repeated spontaneous abortions. Int J Fertil 1990;35:266–270.
- Gadow EC, Lippold S, Otano L, Serafin E, Scarpati R, Matayoshi T: Chromosome rearrangements among couples with pregnancy losses and other adverse reproductive outcomes. Am J Med Genet 1991;41:279–281.
- Fryns JP, Van Buggenhout G: Structural chromosome rearrangements in couples with recurrent fetal wastage. Eur J Obstet Gynecol Reprod Biol 1998;81:171–176.
Meza Espinoza JP, Ortiz Anguiano L, Rivera Ramírez H: Chromosomal abnormalities in couples with reproductive disorders from Mexican West (in Spanish). Rev Invest Clin 2004;56:823–824.
- Castillo S, Sanz P, Astete C, Daher V, Tobella L, Salazar S: Results of chromosomal studies in 270 couples with reproductive problems. Rev Chil Obstet Ginecol 1991;56:38–42.
- Radojcic BA, Buretic-Tomljanovic A, Starcevic N, Kapovic M, Vlastelic I, Randic L: Chromosome studies in patients with defective reproductive success. Am J Reprod Immunol 2000;44:279–283.
- Cantú JM, Hernández A, Jiménez-Sainz M, Moller M, Rolón A, González-Flores O, Rivera H: Chromosome aberrations in 334 individuals with various types of abortion (including 144 couples) (in Spanish). Rev Invest Clin 1985;37:131–134.
- Orozco Quiyono M, Grether P, Zavaleta MJ, Manzanero J: Cytogenetic study in disorders of human reproduction (in Spanish). Ginecol Obstet Mex 1994;62:23–26.
- Teo SH, Tan M, Knight L, Yeo SH, Ng I: Pericentric inversion 9 – incidence and clinical significance. Ann Acad Med Singapore 1995;24:302–304.
- Ishikawa M, Hidaka E, Wakui K, Fukushima Y, Katsuyama T: Habitual abortion and high frequency of low frequent X chromosome monosomy mosaicism: detection by interphase FISH analysis of buccal mucosa cells and lymphocytes. Rinsho Byori 2000;48:955–959.
- Ward KJ: Genetic factors in recurrent pregnancy loss. Semin Reprod Med 2000;18:425–432.
- Lanasa MC, Hogge WA, Kubik C, Blancato J, Hoffman E: Highly skewed X-chromosome inactivation is associated with idiopathic recurrent spontaneous abortion. Am J Hum Genet 1999;65:252–254.
- Robinson WP, Beever C, Brown CJ, Stephenson MD: Skewed X inactivation and recurrent spontaneous abortion. Semin Reprod Med 2001;19:175–181.
- Lanasa MC, Hogge WA: X chromosome defects as an etiology of recurrent spontaneous abortion. Semin Reprod Med 2000;18:97–103.
- Trkova M, Kapras J, Bobkova K, Stankova J, Mejsnarova B: Increased micronuclei frequencies in couples with reproductive failure. Reprod Toxicol 2000;14:331–335.
- Schlegelberger B, Gripp K, Grote W: Common fragile sites in couples with recurrent spontaneous abortions. Am J Med Genet 1989;32:45–51.
- Rubio C, Simon C, Blanco J, Vidal F, Minguez Y, Egozcue J, Crespo J, Remohí J, Pellicer A: Implications of sperm chromosome abnormalities in recurrent miscarriage. J Assist Reprod Genet 1999;16:253–258.
- McLachlan RI, Mallidis C, Ma K, Bhasin S, de Kretser DM: Genetic disorders and spermatogenesis. Reprod Fertil Dev 1998;10:97–104.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.